| 0 (0%) | 09-27 11:11 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 44.45  |
1-year : | 49.01 |
| Resists | First : | 38.05 |
Second : | 41.96 |
| Pivot price | 38.22 |
|||
| Supports | First : | 31.74 |
Second : | 26.4 |
| MAs | MA(5) : | 37.19 |
MA(20) : | 37.67 |
| MA(100) : | 45.45 |
MA(250) : | 0 | |
| MACD | MACD : | -0.7 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 20.1 |
D(3) : | 41.2 |
| RSI | RSI(14): 29 |
|||
| 52-week | High : | 60.72 | Low : | 31.74 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IMRA ] has closed below the lower bollinger band by 10.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ IMRA ] is to continue within current trading range. Bollinger Bands are 5.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 32.92 - 33.15 | 33.15 - 33.33 |
| Low: | 31.15 - 31.45 | 31.45 - 31.69 |
| Close: | 31.89 - 32.31 | 32.31 - 32.63 |
Fri, 26 Sep 2025
Imra America and Toptica Sign Agreement | light speed | Dec 2007 - Photonics Spectra
Mon, 22 Sep 2025
IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training - PR Newswire
Fri, 12 Sep 2025
IMRA Announces Irish Teams for WMTRC 2025 in Canfranc-Pirineos - Athletics Ireland
Fri, 29 Aug 2025
Australian-first surgical robotics curriculum aiming to address gender gap in medicine - EducationHQ
Mon, 16 Jun 2025
Melbourne start-up worth $25m on cap raise for new surgical tool - The Australian
Thu, 03 Apr 2025
Bitwise Rolls Out 3 New Option Income ETFs - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|